Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

An Erratum to this article was published on 01 June 1995

This article has been updated

Abstract

A crucial requirement in the rational design of a prophylactic vaccine against the hu-uman immunodeficiency virus (HIV) is to establish whether or not protective immunity can occur following natural infection. The immune response to HIV infection is characterized by very vigorous HIV-specific cytotoxic T-lymphocyte (CTL) activity. We have identified four HIV-1 and HIV-2 cross-reactive peptide epitopes, presented to CTL from HIV-infected Gambians by HLA-B35 (the most common Gambian class I HLA molecule). These peptides were used to elicit HIV-specific CTLs from three out of six repeatedly exposed but HIV-seronegative female prostitutes with HLA-B35. These women remain seronegative with no evidence of HIV infection by polymerase chain reaction or viral culture. Their CTL activity may represent protective immunity against HIV infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Change history

  • 01 June 1995

    HIV-speciflc cytotoxic T-cells in HIV-exposed but uninfected Gambian women S. Rowland-Jones, J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. Mcadam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, Andrew Mcmichael & H. Whittle Nature Medicine 1, 59–64, 1995. An error in typography resulted in the incorrect printing of m for the Greek character μ.

References

  1. Ho, D.D., Moudgil, T. & Alam, M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl J. Med. 321, 1621–1625 (1989).

    Article  CAS  PubMed  Google Scholar 

  2. Schecter, M.T. et al. HIV-1 and the aetiology of AIDS. Lancet 341, 658–659 (1993).

    Article  Google Scholar 

  3. Clerici, M. et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. infect Dis. 165, 1012–9 (1992).

    Article  CAS  PubMed  Google Scholar 

  4. Clerici, M. & Shearer, G., A Thl→ Th2 switch is a critical step in the aetiology of HIV infection. Immunol Today 14, 107–111 (1993).

    Article  CAS  PubMed  Google Scholar 

  5. Clerici, M. et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 7, 1427–33 (1993).

    Article  CAS  PubMed  Google Scholar 

  6. Clerici, M. et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. J.A.M.A. 271, 42–6 (1994).

    Article  CAS  PubMed  Google Scholar 

  7. Levy, J.A. HIV pathogenesis and long-term survival. AIDS 7, 1401–1410 (1993).

    Article  CAS  PubMed  Google Scholar 

  8. Miedema, F., Meyaard, L. & Klein, M.R. . Protection from HIV or AIDS? Science 262, 1074–1075 (1993).

    Article  CAS  PubMed  Google Scholar 

  9. Salk, J., Bretscher, P.A., Salk, P.L., Clerici, M. and Shearer, G.M. . Protection from HIV or AIDS? Science 262, 1075–1076 (1993).

    Article  CAS  PubMed  Google Scholar 

  10. Cheynier, R. et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur. J. Immunol 22, 2211–2217 (1992).

    Article  CAS  PubMed  Google Scholar 

  11. Rowland-Jones, S.L. et al. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet 341, 860–861 (1993).

    Article  CAS  PubMed  Google Scholar 

  12. Aldhous, M.C., Watret, K.C., Mok, J.Y., Bird, A.G. and Froebel, K.S. . Cytotoxic T lymphocyte activity and CDS subpopulations in children at risk of HIV infection. Clin. Exp. Immunol 97, 61–7 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Langlade-Demoyen, P., Ngo-Giang-Huong, N., Ferchal, F. and Oksenhendler, E. . HIV nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. clin. Invest. 93, 1293–1297 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Walker, B.D. et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345–8 (1987).

    Article  CAS  PubMed  Google Scholar 

  15. Plata, F. et al. AIDS virus specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348–351 (1987).

    Article  CAS  PubMed  Google Scholar 

  16. Carmichael, A., Jin, X., Sissons, p. and Borysiewicz, L. . Quantitative analysis of the human immunodeficiency virus type 1 (HlV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. exp. Med. 177, 249–56 (1993).

    Article  CAS  PubMed  Google Scholar 

  17. Kalams, S.A. et al. Longitudinal analysis of TCR gene usage by HIV-1 envelope-specific CTL clones reveals a limited TCR repertoire. J. exp. Med. 179, 1261–1271 (1994).

    Article  CAS  PubMed  Google Scholar 

  18. Mabey, D.C.W. et al. Human retroviral infections in The Gambia, prevalence and clinical features. Br. med. J. 296, 83–86 (1988).

    Article  CAS  Google Scholar 

  19. Wilkins, A. et al. Trends in HIV-1 and HIV-2 infection in The Gambia. AIDS 5, 1529–30 (1991).

    Article  CAS  PubMed  Google Scholar 

  20. Pickering, H., Quigley, M., Pepin, J., Todd, J. & Wilkins, A. The effects of post-test counselling on condom use among prostitutes in The Gambia. AIDS 7, 271–3 (1993).

    Article  CAS  PubMed  Google Scholar 

  21. Nixon, D.F. et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with re-combinant vaccinia virus and synthetic peptides. Nature 336, 484–487 (1988).

    Article  CAS  PubMed  Google Scholar 

  22. Elliott, T., Smith, M., Driscoll, P. and McMichael, A. . Peptide selection by class I molecules of the MHC. Curr. Opin. Immunol. 3, 854–866 (1993).

    CAS  Google Scholar 

  23. Allsopp, C.E. et al. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am. J. hum. Genet. 50, 411–21 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Martinon, F., Gomard, E., Hannoun, C. and Levy, J.-P. In vitro human CTL responses against influenza A virus can be induced and selected by synthetic peptides. Eur. J. Immunol. 21, 2171–2176 (1990).

    Article  Google Scholar 

  25. Hill, A.V.S. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434–439 1992.

    Article  CAS  PubMed  Google Scholar 

  26. Kos, F.J. and Mullbacher, A., Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7. Eur. J. Immunol. 22, 3183–5 1992.

    Article  CAS  PubMed  Google Scholar 

  27. Neefjes, J.J., Breur-Vriesendorp, B.S., Van Seventer, G.A., Ivanyi, P. and Ploegh, H. L. . An improved biochemical method for the analysis of HLA class I antigens. Definition of new HLA class I subtypes. Hum. Immunol. 16, 169–181 (1986).

    Article  CAS  PubMed  Google Scholar 

  28. Culmann, B., Gomard, E. and Kieny, M.-P. . Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J. Immunol. 146, 1560–1565 (1991).

    CAS  PubMed  Google Scholar 

  29. Gotch, F. et al. Cytotoxic T cells in HIV-2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 151, 3361–9 (1993).

    CAS  PubMed  Google Scholar 

  30. Schulz, T.F. et al. Biological and molecular variability of HIV-2 isolates from The Gambia. J. Virol 64, 5177–5182 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steitz, T. A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783–1790 (1992).

    Article  CAS  PubMed  Google Scholar 

  32. Shugars, D.C. et al. Analysis of HIV-1 nef gene sequences present in vivo. J. Virol. 67, 4639–4650 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Silver, J., Maudru, T., Fujita, K. and Repaske, R. . An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. N.A.R. 21, 3593–3594 (1993).

    Article  CAS  Google Scholar 

  34. Safrit, J.T., Andrews, C.A., Zhu, T., Ho, D.D. & Koup, R. A. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. exp. Med. 179, 463–72 (1994).

    Article  CAS  PubMed  Google Scholar 

  35. Burrows, S.R., R., Khanna, Burrows, J.M. and Moss, D.J. . An alloresponse in humans is dominated by CTL cross-reactive with a single EBV CTL epitope, implications for graft-versus-host disease. J. exp. Med. 179, 1155–1161 (1994).

    Article  CAS  PubMed  Google Scholar 

  36. Carbone, F.R., Moore, M.W., Sheil, J.M. and Bevan, M.J. . Induction of CTL by primary in vitro stimulation with peptides. J. exp. Med. 167, 1767–1779 (1989).

    Article  Google Scholar 

  37. Macatonia, S.E., Taylor, P.M., Knight, S.C. and Askonas, B.A. . Primary stimulation by dendritic cells induces antiviral proliferativeand cytototic T cell responses in vitro. J. exp. Med. 1255–1264 (1989)

    Article  CAS  PubMed  Google Scholar 

  38. De Bruijn, M. et al. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur. J. Immunol. 22, 3013–20 (1992).

    Article  CAS  PubMed  Google Scholar 

  39. Schild, H. et al. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. exp. Med. 174, 1665–8 (1991).

    Article  CAS  PubMed  Google Scholar 

  40. Salk, J., Bretscher, P.A., Salk, P.L., Clerici, M. and Shearer, G.M. . A strategy for prophylactic vaccination against HIV. Science 260, 1270–1272, 1993.

    Article  CAS  PubMed  Google Scholar 

  41. Clerici, M. et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391–1395, 1994.

    Article  CAS  PubMed  Google Scholar 

  42. Bretscher, P.A., Wei, G., Menon, J.N. and Bielefeldt-Ohmann, H. . Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major. Science 257, 539–542 (1992).

    Article  CAS  PubMed  Google Scholar 

  43. Markovitz, D.M. Infection with the human immunodeficiency virus type 2. Ann. intern. Med. 118, 211–8, (1993).

    Article  CAS  PubMed  Google Scholar 

  44. Simon, F. et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 7, 1411–1417 (1993).

    Article  CAS  PubMed  Google Scholar 

  45. De Cock, K.M. et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. J.A.M.A. 270, 2083–6 (1993).

    Article  CAS  PubMed  Google Scholar 

  46. Robert-Guroff, M. et al. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol. 66, 3602–8 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Pinto, L.A., Covas, M. and Victorino, R.M.M. . T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. AIDS 7, 1389–1391 (1993)

    Article  CAS  PubMed  Google Scholar 

  48. Nixon, D.F. et al. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS 4, 841–5 (1990).

    Article  CAS  PubMed  Google Scholar 

  49. Phillips, R.E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453–9 (1991).

    Article  CAS  PubMed  Google Scholar 

  50. Johnson, R.P., Trocha, A., Buchanan, T.M. and Walker, B.D. . Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. exp. Med. 175, 961–71 (1992).

    Article  CAS  PubMed  Google Scholar 

  51. Johnson, R.P., Trocha, A., Buchanan, T.M. and Walker, B. D. . Recognition of a highly conserved region of human immunodeficiency virus type 1 gp 120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67, 438–45 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  52. George, J.R. et al. Prevalence of HIV-1 and HlV-2 mixed infections in Cote D'lvoire. Lancet 340, 337–339 (1992).

    Article  CAS  PubMed  Google Scholar 

  53. Peeters, M. et al. Virological and PCR studies of HIV-l/HIV-2 dual infection in Cote d'lvoire. Lancet 340, 339–340 (1992).

    Article  CAS  PubMed  Google Scholar 

  54. Leonard, G. et al. Characterisation of dual HIV-1 and HIV-2 serological profiles by PCR. AIDS 7, 1185–1189 (1993).

    Article  CAS  PubMed  Google Scholar 

  55. Mullbacher, A. The long-term maintenance of CTL memory does not require persistence of antigen. J. exp. Med. 179, 317–321 (1994).

    Article  CAS  PubMed  Google Scholar 

  56. Lau, L.L., Jamieson, B.D., Somasundaram, T. and Ahmed, R. . Cytotoxic T-cell memory without antigen. Nature 369, 648–52 (1994).

    Article  CAS  PubMed  Google Scholar 

  57. Gray, D. and Matzinger, P., T cell memory is sho: t-lived in the absence of antigen. J. exp. med. 174, 969–974 (1991).

    Article  CAS  PubMed  Google Scholar 

  58. Simmonds, P. et al. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64, 864–72 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Berry, N.J. HIV-2 proviral load measured by quantitative PCR correlates with CD4+ lymphopaenia in HIV-2 infected individuals. AIDS Research and Human Retroviruses. 8, 1031–1037 (1994).

    Article  Google Scholar 

  60. Lee, S. et al. EBV isolates with the major HLA B35.ø - restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.ø1 positive African population. Ev. J. Immun. (in the press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rowland-Jones, S., Sutton, J., Ariyoshi, K. et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1, 59–64 (1995). https://doi.org/10.1038/nm0195-59

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0195-59

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing